Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3871-3880 of 4090 results

Catalogue Number:

PX-TA1211

Category:

G

Proteo Genix logo

Solanezumab Biosimilar – Anti-APP Abeta/soluble monomer mAb – Research Grade

Target: APP Abeta/soluble monomer
Target Alias Name: Solanezumab/LY2062430/APP Abeta/soluble monomer/anti-APP Abeta/soluble monomer
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1282

Category:

G

Proteo Genix logo

Solitomab Biosimilar – Anti-CD3E/ EpCAM mAb – Research Grade

Target: CD3E/ EpCAM
Target Alias Name: Solitomab/MT110/CD3E/ EpCAM/anti-CD3E/ EpCAM
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: (scFv-kappa-heavy)-(scFv-heavy-kappa)
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2142

Category:

G

Proteo Genix logo

Solrikitug Biosimilar – Anti-TSLP mAb – Research Grade

Target: TSLP
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1606

Category:

G

Proteo Genix logo

Sonelokimab Biosimilar – Anti-ALB/IL17A mAb – Research Grade

Target: ALB/IL17A
Target Alias Name: Sonelokimab /M-1095/MSB-0010841/ALB/IL17A/anti-ALB/IL17A
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: VH-VH'-VH
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1934

Category:

G

Proteo Genix logo

Sonepcizumab Biosimilar – Anti-S1P mAb – Research Grade

Target: S1P
Target Alias Name: anti-S1P/ Sphingosine-1-phosphate
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/ kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1179

Category:

G

Proteo Genix logo

Sontuzumab Biosimilar – Anti-MUC1/ CD227 mAb – Research Grade

Target: MUC1/ CD227
Target Alias Name: Sontuzumab/AS1402/huHMFG-1/MUC1/ CD227/anti-MUC1/ CD227
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1772

Category:

G

Proteo Genix logo

Sotevtamab Biosimilar – Anti-APOJ mAb – Research Grade

Target: APOJ
Target Alias Name: Sotevtamab/16B5/ AB-16B5/APOJ/anti-APOJ
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1716

Category:

G

Proteo Genix logo

Sotigalimab Biosimilar – Anti-CD40 mAb – Research Grade

Target: CD40
Target Alias Name: Sotigalimab/APX-005/IMMUNOGLOBULIN G1 (270-GLUTAMIC ACID/ C-TERMINAL-LYSINE-CLIPPED)/ ANTI-(HUMAN CD40 ANTIGEN) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX005M .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX005M .KAPPA.-CHAIN/ DIMER/ CD40 AGONISTIC MONOCLONAL ANTIBODY APX005M/ EPI-0050/CD40/anti-CD40
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1637

Category:

G

Proteo Genix logo

Sotrovimab Biosimilar – Anti-Spike glycoprotein mAb – Research Grade

Target: Spike glycoprotein
Target Alias Name: Sotrovimab //Spike glycoprotein/anti-Spike glycoprotein
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: Human IgG
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1951

Category:

G

Proteo Genix logo

Sovipostobart Biosimilar – Anti-CD152 mAb – Research Grade

Target: CD152
Target Alias Name: anti-CD152/ Cytotoxic T-lymphocyte protein 4/ CTLA-4/ CTLA4/ Cytotoxic T-lymphocyte-associated antigen 4
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo